← Open Payments lookup

REGINALD CASILANG: Open Payments

NPI 1780784488 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,862 in 133 payments from 16 companies in 2025. Trend: 2023 $1,851 · 2024 $2,141 · 2025 $2,862

Food & beverage: $2,862
CompanyPaymentsAmount
ABBVIE INC.19$393
Janssen Pharmaceuticals, Inc10$357
Otsuka America Pharmaceutical, Inc.14$337
Teva Pharmaceuticals USA, Inc.11$305
E.R. Squibb & Sons, L.L.C.11$247
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$235
Alkermes, Inc.12$219
Noven Therapeutics, LLC11$201
Takeda Pharmaceuticals U.S.A., Inc.13$136
Lundbeck LLC5$112

Products named: VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, COBENFY, CAPLYTA, ARISTADA, Xelstrym.

Industry payments across CA — which companies pay providers there.